In The News Posted January 2, 2020 Share Posted January 2, 2020 SAN DIEGO, Jan. 2, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13th at 4:00 p.m. PST/ 7:00 p.m. EST. Charles M. Baum, M.D.,... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.